Literature DB >> 24070080

Endovascular treatment of a mycotic intracavernous carotid artery aneurysm using a stent graft.

Vivek Gupta1, Vikash Jain, S N Mathuria, N Khandelwal.   

Abstract

Intracavernous carotid artery mycotic aneurysms are rare and management is determined by clinical presentation. We describe the first documented proximal intracranial mycotic aneurysm treated by a balloon expandable Aneugraft PCS covered stent. An 11-year-old female child presented with acute onset fever, headache, chemosis followed by diplopia, right-sided ptosis with ophthalmoplegia. Magnetic resonance imaging revealed bilateral cavernous sinus thrombosis. Subsequent work-up included serial computed tomographic arteriography and digital subtraction angiography which revealed a progressively enlarging intracavernous carotid aneurysm. An Aneugraft PCS covered stent was successfully deployed endovascularly, and complete exclusion of the aneurysm was achieved while maintaining the patency of the parent artery. The use of covered stents in intracranial vasculature can be an effective and safe treatment modality for exclusion of the mycotic aneurysm in selected cases.

Entities:  

Mesh:

Year:  2013        PMID: 24070080      PMCID: PMC3806006          DOI: 10.1177/159101991301900308

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  13 in total

1.  Infectious intracranial aneurysms: comparison of groups with and without endocarditis.

Authors:  D L Barrow; A R Prats
Journal:  Neurosurgery       Date:  1990-10       Impact factor: 4.654

2.  Infectious aneurysm of the cavernous carotid artery in a child treated with a new-generation of flow-diverting stent graft: case report.

Authors:  Geoffrey Appelboom; Khaled Kadri; Farouk Hassan; Xavier Leclerc
Journal:  Neurosurgery       Date:  2010-03       Impact factor: 4.654

3.  Intracranial mycotic aneurysms of extravascular origin.

Authors:  C Suwanwela; N Suwanwela; S Charuchinda; C Hongsaprabhas
Journal:  J Neurosurg       Date:  1972-05       Impact factor: 5.115

4.  The importance of repeated angiography in the treatment of mycotic-embolic intracranial aneurysms.

Authors:  R C Cantu; M LeMay; H A Wilkinson
Journal:  J Neurosurg       Date:  1966-08       Impact factor: 5.115

5.  Management of intracranial infectious aneurysms: a series of 16 cases.

Authors:  Loi K Phuong; Michael Link; Eelco Wijdicks
Journal:  Neurosurgery       Date:  2002-11       Impact factor: 4.654

6.  Mycotic intracavernous carotid aneurysm.

Authors:  Tanya Yuen; John D Laidlaw; Peter Mitchell
Journal:  J Clin Neurosci       Date:  2004-09       Impact factor: 1.961

7.  Preliminary experience with endovascular reconstruction for the management of carotid blowout syndrome.

Authors:  Walter S Lesley; John C Chaloupka; John B Weigele; Sundeep Mangla; Mohammad A Dogar
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

8.  Bacterial aneurysms of the intracavernous carotid artery.

Authors:  D Rout; A Sharma; P K Mohan; V R Rao
Journal:  J Neurosurg       Date:  1984-06       Impact factor: 5.115

9.  Serial MRI of a mycotic aneurysm of the cavernous carotid artery.

Authors:  G C Cloud; P M Rich; H S Markus
Journal:  Neuroradiology       Date:  2003-06-17       Impact factor: 2.804

10.  Mycotic aneurysm of the intracavernous portion of the carotid artery in childhood. Case report.

Authors:  T Tomita; D G McLone; T P Naidich
Journal:  J Neurosurg       Date:  1981-05       Impact factor: 5.115

View more
  2 in total

1.  Equine pericardium-covered stenting in post-traumatic pseudoaneurysm of cavernous internal carotid artery.

Authors:  Jorge L Gonzalez-Cantero; Mariano Del Valle Diéguez; Cristina Monteserín Matesanz; Javier Saura Lorente; Francisco Villoria Medina; Fernando Fortea Gil; Enrique Castro Reyes
Journal:  Interv Neuroradiol       Date:  2018-07-05       Impact factor: 1.610

2.  An Infected Aneurysm of the Vertebral Artery Treated with a Stent-graft: A Case Report.

Authors:  Kenji Hashimoto; Fumiaki Isaka; Kohsuke Yamashita
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-10-06       Impact factor: 1.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.